Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurohormones in patients with ischemic left ventricular dysfunction

H Pouleur1, C R Benedict, M F Rousseau

  • 1Division of Cardiology, University of Louvain, Medical School, Brussels, Belgium.

Cardiovascular Drugs and Therapy
|May 1, 1994
PubMed
Summary

Neurohormonal systems are activated in left ventricular dysfunction, impacting prognosis and disease progression. While ACE inhibitors improve outcomes, novel therapies are needed to address remaining neurohormonal activation and reduce high mortality rates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipoprotein(a) levels are doubled in left-handed patients with diabetes.

Diabetes & metabolism·2018
Same author

Measurement of Galectin-3 with the ARCHITECT assay: Clinical validity and cost-effectiveness in patients with heart failure.

Clinical biochemistry·2014
Same author

Galectin-3 testing: validity of a novel automated assay in heart failure patients with reduced ejection fraction.

Clinica chimica acta; international journal of clinical chemistry·2013
Same author

What is the phenotype of patients with gastrointestinal intolerance to metformin?

Diabetes & metabolism·2013
Same author

Comparison between intact and bioactive parathyroid hormone assays in patients with severe heart failure.

Clinical biochemistry·2012
Same author

Increased circulating concentrations of bioactive PTH 1-84 in patients with heart failure.

Journal of endocrinological investigation·2012

Area of Science:

  • Cardiology
  • Pharmacology
  • Biochemistry

Background:

  • Neurohormonal systems are activated in patients with left ventricular dysfunction, even without overt heart failure symptoms.
  • This activation indicates a non-steady cardiovascular state and identifies factors contributing to disease progression.
  • Plasma neurohormone levels, especially norepinephrine, hold significant prognostic value.

Purpose of the Study:

  • To investigate the role of neurohormonal activation in left ventricular dysfunction.
  • To explore the therapeutic potential of targeting neurohormonal systems for improved patient outcomes.
  • To identify limitations of current therapies and explore future treatment strategies.

Main Methods:

  • Measurement of plasma neurohormones in patients with left ventricular dysfunction.

Related Experiment Videos

  • Analysis of the prognostic value of specific neurohormone levels.
  • Evaluation of therapeutic interventions targeting neurohormonal pathways, including ACE inhibitors and beta-blockers.

    • Main Results:

    • Studies show activation of multiple neurohormonal systems in left ventricular dysfunction.
    • Plasma norepinephrine levels are linked to prognosis.
    • Angiotensin-converting enzyme (ACE) inhibitors and beta-blockers have demonstrated therapeutic success.
    • Despite treatment, significant morbidity and mortality persist due to incomplete neurohormonal control and factors like endothelin-1.

    Conclusions:

    • Neurohormonal activation is a key feature of left ventricular dysfunction with prognostic implications.
    • Current therapies like ACE inhibitors offer benefits but do not fully resolve the issue.
    • Further research into novel therapeutic approaches, potentially including long-acting dihydropyridines, is warranted to improve outcomes in severe ischemic left ventricular dysfunction.